Cargando…

Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States

BACKGROUND: The economic burden of Clostridium difficile infection (CDI), the leading cause of nosocomial infectious diarrhea, is not well understood. The objective of this study was to estimate the healthcare resource utilization (HCRU) and costs attributable to primary CDI and recurrent CDI (rCDI)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dongmu, Prabhu, Vimalanand S, Marcella, Stephen W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905590/ https://www.ncbi.nlm.nih.gov/pubmed/29360950 http://dx.doi.org/10.1093/cid/cix1021

Ejemplares similares

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach
por: Desai, Kamal, et al.
Publicado: (2016)

Healthcare Resource Utilization for Recurrent Clostridium difficile Infection in a Large University Hospital in Houston, Texas
por: Aitken, Samuel L., et al.
Publicado: (2014)

Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection
por: Ramsay, Isobel, et al.
Publicado: (2018)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
por: Gerding, Dale N, et al.
Publicado: (2018)

Clostridium difficile: the increasingly difficult pathogen
por: Pop-Vicas, Aurora, et al.
Publicado: (2008)

Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
por: Prabhu, Vimalanand S, et al.
Publicado: (2017)

Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease Recurrence
por: Kumar, Nitin, et al.
Publicado: (2016)

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
por: Priyadarshini, Masoom, et al.
Publicado: (2021)

Determining Mortality Rates Attributable to Clostridium difficile Infection
por: Hota, Susy S., et al.
Publicado: (2012)

Attributing Cause of Death for Patients with Clostridium difficile Infection
por: Gilca, Rodica, et al.
Publicado: (2012)

Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan
por: Kimura, T., et al.
Publicado: (2020)

Clostridium difficile–associated Disease in the Elderly, United States
por: Jagai, Jyotsna, et al.
Publicado: (2009)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
por: Priyadarshini, Masoom, et al.
Publicado: (2021)

Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection
por: Millan, Braden, et al.
Publicado: (2016)

Tea and Recurrent Clostridium difficile Infection
por: Oman Evans II, Martin, et al.
Publicado: (2016)

Burden of Clostridium difficile on the Healthcare System
por: Dubberke, Erik R., et al.
Publicado: (2012)

Assessment of Reporting Bias for Clostridium difficile Hospitalizations, United States
por: Zilberberg, Marya D.
Publicado: (2008)

Clostridium difficile Infection, Colorado and the Northwestern United States, 2007
por: Kuntz, Jennifer L., et al.
Publicado: (2012)

Healthcare resource utilization and cost among patients with type 1 diabetes in the United States
por: Simeone, Jason C, et al.
Publicado: (2020)

534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States
por: Liu, Gui, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2016)

Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection
por: Dehlholm-Lambertsen, Emilie, et al.
Publicado: (2019)

Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study
por: Zhang, Shanshan, et al.
Publicado: (2016)

Attributable Outcomes of Endemic Clostridium difficile–associated Disease in Nonsurgical Patients
por: Dubberke, Erik R., et al.
Publicado: (2008)

A prediction model for Clostridium difficile recurrence
por: LaBarbera, Francis D., et al.
Publicado: (2015)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Hypoalbuminemia as predictor of recurrence of Clostridium difficile infection
por: Knafl, Daniela, et al.
Publicado: (2019)

Updates in Treatment of Recurrent Clostridium difficile Infection
por: Singh, Tanveer, et al.
Publicado: (2019)

Outpatient Healthcare Settings and Transmission of Clostridium difficile
por: Jury, Lucy A., et al.
Publicado: (2013)

Incidence and Costs of Clostridium difficile Infections in Canada
por: Levy, Adrian R., et al.
Publicado: (2015)

Mortality, healthcare resource utilization, and cost among Medicare beneficiaries with Clostridioides difficile infection with and without sepsis
por: Amin, Alpesh, et al.
Publicado: (2022)

Serum Mannose-Binding Lectin Concentration, but Not Genotype, Is Associated With Clostridium difficile Infection Recurrence: A Prospective Cohort Study
por: Swale, Andrew, et al.
Publicado: (2014)

Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
por: Martin, Jessica S H, et al.
Publicado: (2018)

Healthcare Resource Utilization and Costs Among Commercially Insured Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
por: Kobayashi, Monica, et al.
Publicado: (2023)

1921. Attributable Inpatient Costs of Hospital-Onset Clostridium difficile Infection: A Nationwide Case–Control Study in Japan
por: Fukuda, Haruhisa, et al.
Publicado: (2018)

Healthcare resource utilization in a phase 3 trial of SER-109 in patients with recurrent Clostridioides difficile infection
por: Cohen, Stuart, et al.
Publicado: (2022)

Increase in Clostridium difficile–related Mortality Rates, United States, 1999–2004
por: Redelings, Matthew D., et al.
Publicado: (2007)

Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006
por: Vindigni, Stephen M., et al.
Publicado: (2010)

Clostridium difficile Infections among Hospitalized Children, United States, 1997–2006
por: Zilberberg, Marya D., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_56smmb9veeli2ctoq517bhc69v